IntroductionBicuspid aortic valve (BAV) patients have an increased risk to develop thoracic aortic complications. Little is known about the prevalence and severity of atherosclerosis in the BAV... Show moreIntroductionBicuspid aortic valve (BAV) patients have an increased risk to develop thoracic aortic complications. Little is known about the prevalence and severity of atherosclerosis in the BAV ascending aortic wall. This study evaluates and compares the prevalence of thoracic aortic atherosclerosis in BAV and tricuspid aortic valve (TAV) patients.MethodsAtherosclerosis was objectified using three diagnostic modalities in two separate BAV patient cohorts (with and without an aortic dilatation). Within the first group, atherosclerosis was graded histopathologically according to the modified AHA classification scheme proposed by Virmani et al. In the second group, the calcific load of the ascending aorta and coronary arteries, coronary angiographies and cardiovascular risk factors were studied. Patients were selected from a surgical database (treated between 2006-2020), resulting in a total of 128 inclusions.ResultsHistopathology showed atherosclerotic lesions to be more prevalent and severe in all TAV as compared to all BAV patients (OR 1.49 (95%CI 1.14 - 1.94); p = 0.003). Computed tomography showed no significant differences in ascending aortic wall calcification between all BAV and all TAV patients, although a tendency of lower calcific load in favor of BAV was seen. Coronary calcification was higher in all TAV as compared to all BAV (OR 1.30 (95%CI 1.06 - 1.61); p = 0.014).ConclusionAscending aortic atherosclerotic plaques were histologically more pronounced in TAV as compared to the BAV patients, while CT scans revealed equal amounts of calcific depositions within the ascending aortic wall. This study confirms less atherosclerosis in the ascending aortic wall and coronary arteries of BAV patients as compared to TAV patients. These results were not affected by the presence of a thoracic aortic aneurysm. Show less
Bijnen, S. van; Vries-Bouwstra, J. de; Ende, C.H. van den; Boonstra, M.; Kroft, L.; Geurts, B.; ... ; Vonk, M.C. 2020
Background Autologous haematopoietic stem cell transplantation (HSCT) improves survival in systemic sclerosis (SSc) with poor prognosis, but is hampered by treatment-related mortality (TRM).... Show moreBackground Autologous haematopoietic stem cell transplantation (HSCT) improves survival in systemic sclerosis (SSc) with poor prognosis, but is hampered by treatment-related mortality (TRM). Objective To evaluate event-free survival (EFS), TRM, response to treatment, disease progression and patient characteristics associated with events.Methods All patients treated with HSCT for SSc in The Netherlands until 2017 (n=92) were included. Data on skin involvement (modified Rodnan skin score (mRSS), pulmonary function (forced vital capacity (FVC) and diffusion capacity of the lungs for carbon monoxide (DLCO)), extent of interstitial lung disease on high-resolution CT using Goh scores and left ventricular ejection fraction (LVEF) were collected at baseline, 1, 2 and 5 years. Occurrence of events, defined as death or major organ failure, were collected until 2019. As control, a comparison between patients treated with cyclophosphamide (CYC) and patients with HSCT who participated in the Autologous Stem Cell Transplantation International Scleroderma (ASTIS) trial was performed.Results Median follow-up was 4.6 years. EFS estimates at 5, 10 and 15 years were 78%, 76% and 66%, respectively. Twenty deaths occurred. Mean FVC, DLCO, mRSS and Goh scores all improved significantly. Disease progression occurred in 22 patients. Frequency of TRM decreased over time and occurred more often in males. Events were independently associated with male sex, LVEF <50% and older age. In ASTIS, patients treated with HSCT (n=23) 7 events occurred versus 13 in the CYC group (n=22).Conclusion Our data confirm long-term efficacy of HSCT in improving survival, skin and lung involvement in SSc. Male sex, lower LVEF and older age at baseline were identified as risk factors for events. Show less
Elders, B.; Westenberg, J.; Boogaard, P. van den; Calkoen, E.; Blom, N.; Kroft, L.; ... ; Roest, A. 2019
Aim: In patients after atrioventricular septal defect correction, altered geometry leads to a changed position and subsequent flow over the left ventricular outflow tract. We hypothesised that this... Show moreAim: In patients after atrioventricular septal defect correction, altered geometry leads to a changed position and subsequent flow over the left ventricular outflow tract. We hypothesised that this altered flow may influence haemodynamics in the ascending aorta. Methods: In total, 30 patients after atrioventricular septal defect correction (age 27.6 +/- 12.8 years) and 28 healthy volunteers (age 24.8 +/- 13.7 years) underwent 4D flow cardiovascular magnetic resonance. Left ventricular ejection fraction and mean and peak wall shear stress calculated at ascending aortic peak systole were obtained from cardiovascular magnetic resonance. Left ventricular outflow tract data including velocity and diameter were obtained from echocardiography. Results: Patients showed a higher mean (911 +/- 173 versus 703 +/- 154 mPa, p = 0.001) and peak ascending aortic wall shear stress (1264 +/- 302 versus 1009 +/- 240 mPa, p = 0.001) compared to healthy volunteers. Increased blood flow velocities over the left ventricular outflow tract (1.49 +/- 0.30 m/s versus 1.22 +/- 0.20 m/s, p < 0.001) correlated well with mean and peak ascending aortic wall shear stress (r = 0.67, p < 0.001 and r = 0.77, p < 0.001). Conclusion: After atrioventricular septal defect correction, increased wall shear stress was observed, which correlated to velocities over the left ventricular outflow tract. These findings imply that altered outflow tract geometry contributes to changed aortic haemodynamics. Show less
Dogan, H.; Roos, A. de; Geleijins, J.; Huisman, M.; Kroft, L. 2015
Background. Advances in the minimally invasive mitral valve repair techniques increase the demands on accurate and reliable morphologic assessment of the mitral valve using three-dimensional... Show moreBackground. Advances in the minimally invasive mitral valve repair techniques increase the demands on accurate and reliable morphologic assessment of the mitral valve using three-dimensional imaging modalities. The present study compared mitral valve geometry measurements obtained by three-dimensional transesophageal echocardiography (TEE) to those obtained with multidetector row computed tomography (MDCT) used as a standard reference. Methods. Clinical preoperative MDCT and intraoperative three-dimensional TEE were performed in 43 patients (mean age 81.0 +/- 7.7 years) considered for transcatheter valve implantation procedure. Various measurements of mitral valve geometry were obtained from three-dimensional TEE datasets using mitral valve quantification software, and compared with those obtained from MDCT images using multiplanar reformation planes. Results. Moderate and severe mitral regurgitation was present in 48.9% of patients. There was good agreement in mitral valve geometry measurements between three-dimensional TEE and MDCT without significant overestimation or underestimation and tight 95% limits of agreement. For linear dimensions, angles and areas, the 95% limits of agreement were less than 1 cm, less than 15 degrees, and less than 2 cm(2), respectively. In addition, the intraclass correlation coefficients were more than 0.8 for all parameters. Finally, the measurements were highly reproducible, with low intraobserver and interobserver variability (nonsignificant overestimation or underestimation and narrow 95% limits of agreement). Conclusions. The present study demonstrates the accuracy and clinical feasibility of the assessment of the mitral valve geometry with three-dimensional TEE that is comparable to the MDCT measurements. Three-dimensional TEE and MDCT provide accurate and complementary information in the evaluation of patients with mitral valve disease. Its potential incremental clinical value in the field of transcatheter mitral repair procedures needs further assessment in the future studies. (Ann Thorac Surg 2010;90:1922-9) (C) 2010 by The Society of Thoracic Surgeons Show less
Graaf, F.R. de; Werkhoven, J.M. van; Velzen, J. van; Boogers, M.; Antoni, L.; Kroft, L.; ... ; Bax, J.J. 2010
BACKGROUND: Recently a 320-detector-row CT (MDCT) scanner has become available that allows axial volumetric scanning of a 16-cm-long range (50 cm field of view) in a single 0.35-s rotation. For... Show moreBACKGROUND: Recently a 320-detector-row CT (MDCT) scanner has become available that allows axial volumetric scanning of a 16-cm-long range (50 cm field of view) in a single 0.35-s rotation. For imaging neonates and small children, volume scanning is potentially of great advantage as the entire scan range can be acquired in 0.35 s, which can reduce motion artefacts and may reduce the need for sedation in clinical CT imaging. Also, because there is no over-ranging associated with axial volumetric scanning, this may reduce patient radiation dose. OBJECTIVE: To evaluate, by means of a phantom study, scan time and patient dose for thoracic imaging in neonates and small children by using axial cone-beam and helical fan-beam MDCT acquisitions. MATERIALS AND METHODS: Paediatric imaging protocols were assessed for a 320-MDCT volumetric scanner (Aquilion ONE, Toshiba, Otawara, Japan). The 320-MDCT scanner allows for cone-beam acquisitions with coverage up to 160 mm, but it also allows for helical fan-beam acquisitions in 64-, 32-, or 16-MDCT modes. The acquisition configurations that were evaluated were 320 x 0.5 mm, 240 x 0.5 mm, and 160 x 0.5 mm for axial volumetric scanning, and 64 x 0.5 mm, 32 x 0.5 mm, and 16 x 0.5 mm for helical scanning. Dose assessment was performed for clinically relevant paediatric angiographic or chest/mediastinum acquisition protocols with tube voltages of 80 or 100 kVp and tube currents between 40 and 80 mA. RESULTS: Scan time was 0.35 s for 320-MDCT acquisitions, scan times varied between 1.9 s and 8.3 s for helical acquisitions. Dose savings varying between 18% and 40% were achieved with axial volumetric scanning as compared to helical scanning (for 320- versus 64-MDCT at 160 mm and 80 kVp, and for 320- versus 16-MDCT at 80 mm and 100 kVp, respectively). Statistically significant reduction in radiation dose was found for axial 320-MDCT volumetric scanning compared to helical 64-, 32-, and 16-MDCT scanning. CONCLUSION: Axial thoracic CT of neonates and small children with volumetric 320-MDCT can be performed between 5 and 24 times faster compared to helical scanning and can save patient dose. Show less
